← Back

Imperagen

Manchester, United Kingdom

seed$6.7M raisedBiotechDigital HealthEnterprise Software

Total Raised

$6.7M

Stage

seed

Location

Manchester, United Kingdom

Founded

2021

Team size

11-50

Links

About Imperagen

Biotech company using quantum physics and AI to improve enzyme engineering by making it faster, more efficient, and less costly.

What sets it apart

Its closed-loop Digital Enzyme Evolution platform combines AI-led protein design with QM/physics-based simulation and high-throughput robotics to deliver verified enzyme improvements faster and more predictably.

Sectors

BiotechDigital HealthEnterprise SoftwareWorkflow Automation

Business

ModelSaaS

CustomerPharmaceutical manufacturers, life sciences companies, and industrial/fine chemical companies needing custom enzyme optimization and development

Notable

  • Founded in 2021
  • Raised $4.3M in total funding
  • Backed by IQ Capital and Northern Gritstone
  • Based at Manchester Science Park

Backing funds on Raise

Funding rounds

seed$6.7M

20 May 2026

Led by PXN Ventures

With IQ Capital, Northern Gritstone

Source ↗

Explore the market

FAQ

What does Imperagen do?

Biotech company using quantum physics and AI to improve enzyme engineering by making it faster, more efficient, and less costly.

Where is Imperagen based?

Imperagen is based in Manchester, United Kingdom, founded in 2021.

How much has Imperagen raised?

Imperagen has raised $6.7M in tracked funding and is currently at the seed stage.

Who has invested in Imperagen?

Investors in Imperagen include IQ Capital and Northern Gritstone.